Dramatic increases in war-related brain injuries have focused attention on research for more effective treatments. Recent findings have identified new pathways and molecular interactions that point the way towards novel drugs to suppress serious long-term aftereffects such as Parkinson's disease. Neuroscientist
Alan Faden discusses new findings that may improve therapy for traumatic brain injury.
Alan Faden is a professor in the Department of Neuroscience. His research addresses pathobiological mechanisms of neuronal cell death at the molecular and cellular levels.
